Pro-med (Beijing) Technology Co., Ltd

Pro-med (Beijing) Technology limited company was established in 2013 in Changping Zhongguancun Science and Technology Park, focusing on maternal and child health in vitro diagnostics, mainly engaged in the research and development, production, and sales of POCT, coagulation testing equipment. In 2017, Pro-med established Jiangsu Aoya Biotechnology limited company in China Medical City to fully upgrade the R&D center and production factory, has more than 30 core patents and 80 product registration certificates. Mainly export products are covid-19 antigen, covid-19 neutralizing antibody, VD and FER rapid detection kit. Pro-med has more than 8,000 square meters of production research and development sites, 1,500 square meters of GMP workshops, and an annual production capacity of 100 million people. Pro-med has ISO13485 and GMP certification.